SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.451
AS - Asia 8.282
EU - Europa 4.300
SA - Sud America 1.163
Continente sconosciuto - Info sul continente non disponibili 310
AF - Africa 201
OC - Oceania 21
Totale 29.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.107
SG - Singapore 3.243
CN - Cina 2.097
BR - Brasile 919
VN - Vietnam 886
IT - Italia 856
DE - Germania 650
UA - Ucraina 633
HK - Hong Kong 630
GB - Regno Unito 502
TR - Turchia 417
FI - Finlandia 346
PL - Polonia 320
FR - Francia 244
BD - Bangladesh 243
SE - Svezia 203
JP - Giappone 192
RU - Federazione Russa 190
CA - Canada 180
IN - India 147
MX - Messico 106
ID - Indonesia 95
ZA - Sudafrica 76
AR - Argentina 73
IQ - Iraq 65
BE - Belgio 57
NL - Olanda 57
AT - Austria 53
CO - Colombia 45
PK - Pakistan 39
ES - Italia 38
MA - Marocco 36
EC - Ecuador 35
CZ - Repubblica Ceca 33
LT - Lituania 26
UZ - Uzbekistan 26
VE - Venezuela 26
SA - Arabia Saudita 25
PY - Paraguay 20
MY - Malesia 19
AU - Australia 18
PH - Filippine 18
AE - Emirati Arabi Uniti 17
CL - Cile 17
IR - Iran 17
ET - Etiopia 16
KE - Kenya 16
JM - Giamaica 15
EG - Egitto 13
NP - Nepal 13
DZ - Algeria 12
UY - Uruguay 12
PE - Perù 11
IE - Irlanda 10
NO - Norvegia 10
PT - Portogallo 10
RO - Romania 10
JO - Giordania 9
TN - Tunisia 9
AZ - Azerbaigian 8
KR - Corea 8
KZ - Kazakistan 8
LB - Libano 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CR - Costa Rica 7
HN - Honduras 7
AL - Albania 6
BG - Bulgaria 6
CH - Svizzera 6
EU - Europa 6
IL - Israele 6
NG - Nigeria 6
OM - Oman 6
AO - Angola 5
GR - Grecia 5
GT - Guatemala 5
HR - Croazia 5
TH - Thailandia 5
GE - Georgia 4
MN - Mongolia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SV - El Salvador 4
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
CY - Cipro 2
GD - Grenada 2
KG - Kirghizistan 2
Totale 29.397
Salva come PNG Salva come JPEG
Città #
Singapore 1.991
Ashburn 1.793
Woodbridge 1.339
San Jose 1.141
Fairfield 1.093
Chandler 768
Houston 737
Jacksonville 680
Beijing 667
Santa Clara 662
Hong Kong 621
Ann Arbor 561
Wilmington 396
Seattle 391
Cambridge 362
Warsaw 306
New York 302
Ho Chi Minh City 295
Los Angeles 278
Council Bluffs 250
Izmir 236
Dallas 227
Nanjing 219
Ferrara 198
Hanoi 194
Tokyo 189
Princeton 180
Milan 170
Munich 146
Lauterbourg 143
Helsinki 139
Boardman 130
Shanghai 116
São Paulo 95
San Diego 91
The Dalles 89
Buffalo 84
Addison 81
Dearborn 81
Orem 70
Mexico City 69
Nanchang 67
Turku 66
Brooklyn 64
London 64
Shenyang 63
Jakarta 61
Bremen 59
Brussels 57
Chicago 57
Toronto 57
Montreal 52
Tianjin 52
Phoenix 51
Jiaxing 50
Atlanta 48
Changsha 47
Hebei 46
Chennai 45
Rome 45
Denver 44
Hefei 43
Da Nang 41
Stockholm 41
Johannesburg 38
Norwalk 38
Poplar 38
Bologna 35
Vienna 35
Haiphong 34
San Francisco 33
Falls Church 32
Manchester 31
Baghdad 30
Amsterdam 29
Boston 29
Brno 29
Frankfurt am Main 29
Rio de Janeiro 29
San Mateo 28
Ankara 26
Ningbo 26
Guangzhou 25
Nuremberg 25
Zhengzhou 25
Columbus 24
Jinan 24
Redwood City 24
Tashkent 24
Moscow 23
Orange 23
Biên Hòa 22
Auburn Hills 21
Falkenstein 21
Hải Dương 21
Brasília 19
Kunming 19
Mumbai 19
Curitiba 18
Mountain View 18
Totale 19.764
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 418
An unusual cause of a common symptom: Pyomyositis presenting with sciatica 280
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 279
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 274
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 267
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 261
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 255
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 254
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 254
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 252
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 252
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 250
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 249
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 243
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 242
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 242
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 239
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 238
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 236
HLA-G Molecules in Autoimmune Diseases and Infections 231
Survival prediction in high-grade gliomas using CT perfusion imaging 231
Emerging topics and new perspectives on HLA-G 230
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 227
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 226
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 222
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 218
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 218
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 217
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 217
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 215
Leptin/adiponectin ratio predicts post-stroke neurological outcome 214
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 210
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 210
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 210
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 209
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 208
Cerebrospinal fluid analysis and the determination of oligoclonal bands 208
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 207
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 205
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 198
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 196
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 195
Neurofilament ELISA validation 195
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 194
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 194
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 192
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 192
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 191
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 191
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 190
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 189
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 188
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 187
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 185
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 185
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 185
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 184
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 184
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 184
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 183
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 180
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 180
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 178
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 178
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 176
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 176
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 174
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 173
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 172
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 171
Some basic aspects of HLA-G biology. 171
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 171
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 170
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 169
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 168
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 167
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 167
New insights into HLA-G and inflammatory diseases 166
Endovascular Thrombectomy for Acute Ischemic Stroke beyond 6 Hours from Onset: A Real-World Experience 165
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 162
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 160
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 160
Le catene leggere libere liquorale sclerosi multipla 159
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 157
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 155
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 153
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 153
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 151
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 150
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 149
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 149
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 148
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 148
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 147
Association Between Perihematomal Perfusion and Intracerebral Hemorrhage Outcome 147
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 146
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 145
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 144
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 143
Totale 19.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.215
Totale 137.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.525 0 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/202611.613 1.131 456 853 1.429 1.707 771 1.458 620 1.033 1.138 598 419
2026/2027660 316 344 0 0 0 0 0 0 0 0 0 0
Totale 29.728